| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1467206A Method for preparing 2-chloro-4,6-dimethoxy pyrimidine |
| 01/14/2004 | CN1134438C Bicyclic heteroaromatic compounds, method for prepearing the same and uses |
| 01/14/2004 | CN1134430C Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677345 Cyclin dependent kinase inhibitors |
| 01/13/2004 | US6677344 Chymase inhibitor for the treatment of eosinophilia |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/08/2004 | WO2004003108A1 Luminescent compositions |
| 01/08/2004 | WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain |
| 01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
| 01/08/2004 | WO2004002963A1 Amide derivative |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006162 For use as antidegradant in natural or synthetic rubber |
| 01/08/2004 | US20040006097 For therapy of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis |
| 01/08/2004 | US20040006094 For prophylaxis of ischemic cell death, particularly neuronal cell death, and reduce the likelihood of neuronal cell death in a subject due to a traumatic event |
| 01/08/2004 | US20040006068 Pyrimidine derivatives |
| 01/08/2004 | US20040004207 Difluoromethyl ether derivative and process for producing the same |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378247A1 Visual function improving agents |
| 01/07/2004 | EP1378241A1 Pharmaceutical compositions comprising arsenic for the treatment of melanoma |
| 01/07/2004 | EP1378240A2 Pharmaceutical compositions comprising arsenic for the treatment of multiple myeloma |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377640A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | CN1466582A Substituted aryl ketones and their use as herbicides |
| 01/07/2004 | CN1466419A Stabilized compositions having antibacterial activity |
| 01/07/2004 | CN1133625C Quinazoline derivatives |
| 01/07/2004 | CN1133624C Chloropyrimidine preparation process |
| 01/06/2004 | US6673925 Method of producing thiobarbituric acid derivatives |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics |
| 01/06/2004 | CA2285891C Triazole antifungal agents |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373228A1 Substituted fluoroalcoxyphenylsulfonylurea |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373222A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 01/02/2004 | EP1373221A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373210A1 Heterocyclic diamide invertebrate pest control agents |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372657A2 A method of treating proliferative diseases using eg5 inhibitors |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1140819B1 Alfa-sulfenimino acid derivatives |
| 01/02/2004 | EP1140799B1 Novel propargylether derivatives |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/02/2004 | EP1027339B1 Method and reagents for n-alkylating ureides |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002599 Substituted benzoycyclohexenones |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000820A2 Certain aromatic monocycles as kinase modulators |
| 12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | WO2004000771A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
| 12/31/2003 | WO2004000762A2 Propionic acid derivatives and their use as hppars activators |
| 12/31/2003 | WO2004000318A2 Certain amino-substituted monocycles as kinase modulators |
| 12/31/2003 | WO2003063576A3 Arylsulfonamidobenzylic compounds |
| 12/31/2003 | WO2003000188A3 Novel quinazolines and uses thereof |
| 12/31/2003 | CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
| 12/31/2003 | CN1132815C 杂芳香族醛类的制造方法 The method of manufacturing the heteroaromatic aldehyde |
| 12/31/2003 | CA2489359A1 Propionic acid derivatives and their use as hppars activators |
| 12/30/2003 | US6670645 Bright, efficient, stable; increased volatility for lower temperature vacuum deposition preventing decomposition |
| 12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670368 Pyrimidine compounds with pharmaceutical activity |
| 12/30/2003 | US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists |
| 12/30/2003 | CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia |
| 12/25/2003 | WO2003106572A1 Printing process using specified azo compounds |
| 12/25/2003 | US20030236437 Sulfonation of 1-(5-amino-2,4-dichlorophenyl)-4,5-dihydro-4-difluoromethyl-3-methyl-1,2,4 -triazol-5(1H)-one using mesyl chloride, in the presence of catalysts, to form sulfentrazole used as herbicides or pesticides |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236273 Aryl substituted pyrimidines and the use thereof |
| 12/25/2003 | US20030236261 Potassium channel inhibitors |
| 12/25/2003 | US20030235612 Compounds and compositions for delivering active agents |
| 12/24/2003 | WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
| 12/24/2003 | WO2003106434A1 Process for producing pyrimidine compound |
| 12/24/2003 | WO2003106433A1 Deoxyhypusine-synthase inhibitors, pharmaceuticals comprising said inhibitors and uses thereof |
| 12/24/2003 | WO2003106432A1 Method for producing 4,6-dichloro-5-fluoropyrimidine |
| 12/24/2003 | WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents |